BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8673713)

  • 1. Targeted contrast agents in MR imaging.
    Gupta H; Weissleder R
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):171-84. PubMed ID: 8673713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR contrast agents, the old and the new.
    Bellin MF
    Eur J Radiol; 2006 Dec; 60(3):314-23. PubMed ID: 17005349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular magnetic resonance imaging with targeted contrast agents.
    Artemov D
    J Cell Biochem; 2003 Oct; 90(3):518-24. PubMed ID: 14523986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced tumor MR imaging with gadolinium-loaded polychelating polymer-containing tumor-targeted liposomes.
    Erdogan S; Medarova ZO; Roby A; Moore A; Torchilin VP
    J Magn Reson Imaging; 2008 Mar; 27(3):574-80. PubMed ID: 18219628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal contrast agents for MR imaging.
    Brown JJ
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):25-35. PubMed ID: 8673714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug targeting in magnetic resonance imaging.
    Weissleder R; Bogdanov A; Papisov M
    Magn Reson Q; 1992 Mar; 8(1):55-63. PubMed ID: 1567758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gadolinium-loaded polychelating polymer-containing tumor-targeted liposomes.
    Erdogan S; Torchilin VP
    Methods Mol Biol; 2010; 605():321-34. PubMed ID: 20072891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contrast media in hepatic MRI].
    Grellet J; Bellin MF; Dion E
    J Radiol; 1992 Oct; 73(10):495-9. PubMed ID: 1294722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR imaging of the liver. Contrast agents.
    Mahfouz AE; Hamm B
    Magn Reson Imaging Clin N Am; 1997 May; 5(2):223-40. PubMed ID: 9113673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron oxide MR contrast agents for molecular and cellular imaging.
    Bulte JW; Kraitchman DL
    NMR Biomed; 2004 Nov; 17(7):484-99. PubMed ID: 15526347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast agents for functional and cellular MRI of the kidney.
    Grenier N; Pedersen M; Hauger O
    Eur J Radiol; 2006 Dec; 60(3):341-52. PubMed ID: 16973326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization.
    Kubaska S; Sahani DV; Saini S; Hahn PF; Halpern E
    Clin Radiol; 2001 May; 56(5):410-5. PubMed ID: 11384141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes.
    Briley-Saebo KC; Mulder WJ; Mani V; Hyafil F; Amirbekian V; Aguinaldo JG; Fisher EA; Fayad ZA
    J Magn Reson Imaging; 2007 Sep; 26(3):460-79. PubMed ID: 17729343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lymph node diagnosis with imaging methods. An overview with special reference to recent developments in the area of MR contrast media].
    Mohr U; Weissleder R
    Z Lymphol; 1996 Jun; 20(1):15-20. PubMed ID: 8768044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver MRI with contrast enhancement.
    Runge VM
    Crit Rev Diagn Imaging; 1997 Jun; 38(3):207-30. PubMed ID: 9226107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular coronary MR imaging of human thrombi using EP-2104R, a fibrin-targeted contrast agent: experimental study in a swine model.
    Spuentrup E; Katoh M; Wiethoff AJ; Buecker A; Botnar RM; Parsons EC; Guenther RW
    Rofo; 2007 Nov; 179(11):1166-73. PubMed ID: 17948194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution of Abdoscan in MRI cholangio-pancreatography and MRI urography].
    Lecesne R; Drouillard J; Cissé R; Schiratti M
    J Radiol; 1998 Jun; 79(6):573-5. PubMed ID: 9757288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR imaging of the liver using gadolinium chelates.
    Low RN
    Magn Reson Imaging Clin N Am; 2001 Nov; 9(4):717-43, vi. PubMed ID: 11694435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced MR imaging of the pancreas.
    Kettritz U; Semelka RC
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):87-100. PubMed ID: 8673719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast agents: magnetic resonance.
    Burtea C; Laurent S; Vander Elst L; Muller RN
    Handb Exp Pharmacol; 2008; (185 Pt 1):135-65. PubMed ID: 18626802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.